Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SOUTH POINTE PEDIATRICS, PLLC

NPI: 1235399122 · BROKEN ARROW, OK 74012 · Pediatric Adolescent Medicine Physician · NPI assigned 06/13/2008

$1.89M
Total Medicaid Paid
30,978
Total Claims
30,155
Beneficiaries
35
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSULLIVAN, JULIE (OWNER)
NPI Enumeration Date06/13/2008

Related Entities

Other providers sharing the same authorized official: SULLIVAN, JULIE

ProviderCityStateTotal Paid
GREAT CARE HOME HEALTH, INC. INDIANAPOLIS IN $255K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,673 $234K
2019 2,926 $198K
2020 3,460 $192K
2021 4,948 $310K
2022 6,057 $362K
2023 6,143 $368K
2024 3,771 $226K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,445 8,965 $680K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,361 3,208 $320K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,690 2,690 $248K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,833 2,703 $246K
90460 Immunization administration through 18 years of age via any route, first or only component 5,714 5,687 $231K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 691 691 $62K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 635 626 $30K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 683 672 $19K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 101 101 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 195 194 $9K
99460 66 66 $6K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 153 153 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 380 374 $5K
99238 Hospital discharge day management, 30 minutes or less 52 52 $3K
96127 816 814 $3K
99381 27 27 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 30 30 $2K
83655 189 189 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 25 25 $780.25
87420 39 39 $482.43
96110 Developmental screening, with scoring and documentation, per standardized instrument 38 38 $346.38
85018 99 99 $211.22
90661 43 43 $4.00
90633 123 123 $3.00
90723 441 441 $0.00
90647 393 393 $0.00
90686 493 490 $0.00
90716 13 13 $0.00
90670 659 659 $0.00
90671 197 197 $0.00
96160 224 223 $0.00
90681 93 93 $0.00
90710 12 12 $0.00
90707 12 12 $0.00
90700 13 13 $0.00